News Quantified

AUPH – aurinia pharmaceuticals inc - common shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition [Yahoo! Finance]

MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition

Aurinia Announces Management Transition

Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain [Yahoo! Finance]

Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade) [Seeking Alpha]

-2.3%

BEAT

5.7%

BEAT

-2.6%

MISS

-5.1%

BEAT

Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC

Form 8-K Aurinia Pharmaceuticals For: Mar 20

Form 4 Aurinia Pharmaceuticals For: Mar 06 Filed by: Keenan Greg

Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: TANG KEVIN

Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC

Top News Gainers

12/9 Form SC 13D/A Aurinia Pharmaceuticals Filed by: ILJIN SNT Co., Ltd. 13.5%

12/10 Form 6-K Aurinia Pharmaceuticals For: Dec 10 11.7%

9/9 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is now covered by analysts at Citigroup Inc. They set an "outperform" rating and a $14.00 price target on the stock. 10.3%

11/28 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 9.8%

12/3 Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference 7.1%

3/19 Form 6-K Aurinia Pharmaceuticals For: Mar 18 6.4%

10/15 Does The Aurinia Pharmaceuticals Inc. (TSE:AUP) Share Price Fall With The Market? [Yahoo! Finance News] 6.1%

4/20 Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors 5.4%

12/4 Form 6-K Aurinia Pharmaceuticals For: Dec 03 4.9%

12/10 Form SC 13D/A Aurinia Pharmaceuticals Filed by: ILJIN SNT Co., Ltd. 4.6%

Top News Decliners

10/10 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -13.4%

3/16 Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis -12.3%

3/5 Aurinia Pharmaceuticals' (AUPH) CEO Peter Greenleaf on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -10.4%

3/11 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.3%

3/12 Aurinia Launches Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative -6.7%

8/6 Aurinia Pharmaceuticals, Inc.'s (AUPH) CEO Peter Greenleaf on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.6%

2/22 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.3%

3/17 Form 6-K Aurinia Pharmaceuticals For: Mar 17 -5.5%

2/25 Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team -5.4%

12/2 Aurinia Pharmaceuticals Inc.'s (TSE:AUP) Shift From Loss To Profit [Yahoo! Finance News] -5.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day